.@goKDIGO Controversies Conference on Optimal Anemia Management in CKD
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ kdigo.org/wp-content/uplβ¦
Mechanisms of anemia in CKD ca. 2012 from @JASN_News
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ jasn.asnjournals.org/content/jnephrβ¦
Update on Anemia in ESKD and Earlier Stages of CKD: Core Curriculum 2018 from @AJKDonline @sfishbane
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ ajkd.org/article/S0272-β¦
Potential mechanism of increased CV risk with higher hemoglobin targets in ESA studies
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ ncbi.nlm.nih.gov/pmc/articles/Pβ¦
Anemia in CKD: ESA trials
#KDIGOAnemia πͺπΈ #Nephpearls #NephSecrets
Hypoxia-inducible factor (HIF) gene targets
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ ncbi.nlm.nih.gov/pmc/articles/Pβ¦
PIVOTAL: Among patients undergoing hemodialysis, a high-dose IV Fe regimen administered proactively was superior to a low-dose regimen administered reactively & resulted in lower doses of ESA being administered from @NEJM
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ nejm.org/doi/pdf/10.105β¦
Crosstalk between iron and oxygen sensing
π HIF-dependent gene expression is iron dependent
π Iron-absorbing genes are HIF target genes
π FPN stabilizes HIF-2 in enterocytes
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ kidney-international.org/article/S0085-β¦
Prevalence of anemia of CKD in the US πΊπΈ
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ journals.plos.org/plosone/articlβ¦
Traditionally used markers of iron status, β¬οΈ TSAT, especially TSAT< 10%, is most strongly associated with the risk of adverse outcomes in CKD patients irrespective of serum ferritin level
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ bmcnephrol.biomedcentral.com/track/pdf/10.1β¦
Causes of absolute iron deficiency
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ kdigo.org/wp-content/uplβ¦
Suggested management of reactions to IV iron
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ kdigo.org/wp-content/uplβ¦
HIF in the regulation of FGF23 ca. 2019 from @NatRevNeph
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ nature.com/articles/s4158β¦
Effects of Molidustat in the Treatment of Anemia in CKD ca. 2019 from @CJASN
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ cjasn.asnjournals.org/content/clinjaβ¦
Daprodustat produced dose-dependent changes in hemoglobin over the first 4 weeks after switching from a stable dose of rhEPO as well as maintained hemoglobin target levels over 24 weeks
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ academic.oup.com/ckj/article/12β¦
Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent CKD
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ kidney-international.org/article/S0085-β¦
List of Oral Iron Agents Used for Treating Anemia in Patients With CKD ca. 2019
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ ackdjournal.org/article/S1548-β¦
Iron Preparations in the Treatment of Anemia in Non-Dialysis Dependent CKD ca. 2019
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ ackdjournal.org/article/S1548-β¦
Iron Preparations in the Treatment of Anemia in Dialysis Dependent CKD ca. 2019
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ ackdjournal.org/article/S1548-β¦
Roxadustat for Anemia in CKD | @NEJM
#KDIGOAnemia πͺπΈ #Nephpearls
πΊ nejm.org/do/10.1056/NEJβ¦
Pathogenesis of renal anemia and novel and emerging therapies
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ jasn.asnjournals.org/content/jnephrβ¦
Diagnostic tests and therapeutic targets π― for anemia of CKD
#KDIGOAnemia πͺπΈ #Nephpearls
ππΌ kdigo.org/wp-content/uplβ¦
HIF PHD inhibitors in clinical development ca. 2019
#Nephpearls #Welcome2020
ππΌ asn-online.org/publications/kβ¦
Check out ππΌ Hypoxia-inducible Factor (HIF) Stabilizers for Treating Anemia of CKD
π This is my choice for β‘οΈKidney Watch 2020β‘οΈ published in the February 2020 issue of @KidneyNews
#Nephpearls
ππΌ asn-online.org/publications/kβ¦
Landmark Trials in Anemia and CKD from @RenalFellowNtwk @xaviervel @landmark_neph #Nephpearls
ππΌ renalfellow.org/2020/02/19/lanβ¦
Effect of Ferric Citrate versus Ferrous Sulfate on Iron and Phosphate Parameters in Patients with Iron Deficiency and CKD ca. 2020 from @CJASN #Nephpearls
ππΌ cjasn.asnjournals.org/content/clinjaβ¦
Oral daprodustat was noninferior to darbepoetin alfa as measured by mean hemoglobin over weeks 40β52 in Japanese π―π΅ patients receiving hemodialysis switched from ESAs ca. 2020 from @CJASN #Nephpearls
ππΌ cjasn.asnjournals.org/content/clinjaβ¦
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.